Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07202039 · ClinicalTrials.gov registry record · NA
Electronic Cigarettes as a Harm Reduction Strategy Among People With Opioid Use Disorder on Buprenorphine
A NA study, sponsored by Prisma Health-Upstate.
- Recruiting
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT07202039 is a NA study that is actively recruiting participants, run by Prisma Health-Upstate. The registered enrollment target is 90 participants.
The verdict
NCT07202039, a NA study, is actively recruiting participants, sponsored by Prisma Health-Upstate.
- RECRUITING
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
This project aims to investigate the impact of e-cigarette flavors and usage patterns on achieving harm-reduction milestones in a sample of cigarette smokers with opioid use disorder who are taking buprenorphine
Interventions
- BEHAVIORAL Brief individual counseling sessions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2026-04-29 |
| Est. Completion | 2029-06-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07202039
The ClinicalTrials.gov registry entry for NCT07202039 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Prisma Health-Upstate, which has 67 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Brief individual counseling sessions is the first listed.
NCT07202039 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07202039 about?
NCT07202039 is a clinical study titled "Electronic Cigarettes as a Harm Reduction Strategy Among People With Opioid Use Disorder on Buprenorphine". This project aims to investigate the impact of e-cigarette flavors and usage patterns on achieving harm-reduction milestones in a sample of cigarette smokers with opioid use disorder who are taking buprenorphine
What is the current status of trial NCT07202039?
This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2026-04-29. Estimated completion is 2029-06-29.
What interventions are being tested in trial NCT07202039?
The interventions under investigation include: Brief individual counseling sessions (BEHAVIORAL).
Who is sponsoring clinical trial NCT07202039?
This trial is sponsored by Prisma Health-Upstate, which has 67 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.